[Clinical Practice Guidelines for Smoking Cessation]. 2017

María Paz Corvalán B, and Leonardo Véjar M, and Claudia Bambs S, and Juana Pavié G, and Mónica Zagolin B, and Jaime Cerda L
Centro Médico Fundación del Banco Estado, Santiago, Chile.

Considering that a high proportion of the Chilean general population smokes, the Chilean Society of Respiratory Diseases in collaboration with the Chilean Societies of Cardiology and, Endocrinology and Diabetes, formed an interdisciplinary group, who issued a set of recommendations for the treatment of the smoker, methodologically advised by experts. These interventions should be prioritized in high-risk groups. Methods The panel elaborated and graded the recommendations following the GRADE methodology. To assess the effect of each intervention, systematic reviews and randomized clinical trials were identified. In addition, a search of studies done with the Chilean population was carried out. For each of the questions, the panel determined the direction and strength of the recommendation through a decision evidence table. Recommendations For all smokers, the panel recommends using brief counseling ABC on non-intervention, using mobile telephone interventions on non-intervention, using text message on non-intervention, (strong recommendation; moderate certainty in the evidence of the effects). For motivated individuals, with indication for quitting drugs the panel recommends using nicotine replacement therapy on non-intervention, using bupropion on non-intervention, using varenicline on non-intervention. (strong recommendation; moderate certainty in the evidence of the effects). Discussion This clinical practice guide provides recommendations based on the evidence for smoking cessation.

UI MeSH Term Description Entries
D009538 Nicotine Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine Bitartrate,Nicotine Tartrate
D002677 Chile A country in southern South America, bordering the South Pacific Ocean, between Argentina and Peru.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068580 Varenicline A benzazepine derivative that functions as an ALPHA4-BETA2 NICOTINIC RECEPTOR partial agonist. It is used for SMOKING CESSATION. 6,7,8,9-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)benzazepine,Champix,Chantix,Varenicline Tartrate
D016540 Smoking Cessation Discontinuing the habit of SMOKING. Giving Up Smoking,Quitting Smoking,Stopping Smoking,Cessation, Smoking,Smoking Cessations,Smoking, Giving Up,Smoking, Quitting,Smoking, Stopping,Smokings, Giving Up,Up Smoking, Giving
D016642 Bupropion A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE. (+-)-1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone,Amfebutamone,Bupropion Hydrochloride,Bupropion Hydrochloride, (+-)-Isomer,Bupropion, (+-)-Isomer,Quomen,Wellbutrin,Zyban (Anti-Smoking),Zyban (Bupropion),Zyntabac
D019317 Evidence-Based Medicine An approach of practicing medicine with the goal to improve and evaluate patient care. It requires the judicious integration of best research evidence with the patient's values to make decisions about medical care. This method is to help physicians make proper diagnosis, devise best testing plan, choose best treatment and methods of disease prevention, as well as develop guidelines for large groups of patients with the same disease. (from JAMA 296 (9), 2006) Medicine, Evidence-Based,Evidence Based Medicine,Medicine, Evidence Based

Related Publications

María Paz Corvalán B, and Leonardo Véjar M, and Claudia Bambs S, and Juana Pavié G, and Mónica Zagolin B, and Jaime Cerda L
August 1996, JAMA,
María Paz Corvalán B, and Leonardo Véjar M, and Claudia Bambs S, and Juana Pavié G, and Mónica Zagolin B, and Jaime Cerda L
September 2002, Archives des maladies du coeur et des vaisseaux,
María Paz Corvalán B, and Leonardo Véjar M, and Claudia Bambs S, and Juana Pavié G, and Mónica Zagolin B, and Jaime Cerda L
January 2012, Gaceta medica de Mexico,
María Paz Corvalán B, and Leonardo Véjar M, and Claudia Bambs S, and Juana Pavié G, and Mónica Zagolin B, and Jaime Cerda L
June 2005, Australian family physician,
María Paz Corvalán B, and Leonardo Véjar M, and Claudia Bambs S, and Juana Pavié G, and Mónica Zagolin B, and Jaime Cerda L
March 2023, Journal of the National Comprehensive Cancer Network : JNCCN,
María Paz Corvalán B, and Leonardo Véjar M, and Claudia Bambs S, and Juana Pavié G, and Mónica Zagolin B, and Jaime Cerda L
November 2016, Journal of the National Comprehensive Cancer Network : JNCCN,
María Paz Corvalán B, and Leonardo Véjar M, and Claudia Bambs S, and Juana Pavié G, and Mónica Zagolin B, and Jaime Cerda L
January 2002, Australian family physician,
María Paz Corvalán B, and Leonardo Véjar M, and Claudia Bambs S, and Juana Pavié G, and Mónica Zagolin B, and Jaime Cerda L
June 2005, Australian family physician,
María Paz Corvalán B, and Leonardo Véjar M, and Claudia Bambs S, and Juana Pavié G, and Mónica Zagolin B, and Jaime Cerda L
January 2016, Journal of oncology practice,
María Paz Corvalán B, and Leonardo Véjar M, and Claudia Bambs S, and Juana Pavié G, and Mónica Zagolin B, and Jaime Cerda L
June 2002, Journal of the American Academy of Nurse Practitioners,
Copied contents to your clipboard!